News Image

NASDAQ:VRTX may be ready to breakout.

By Mill Chart

Last update: Oct 4, 2022

VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX) was identified as a Technical Breakout Setup Pattern by our stockscreener. Such a pattern occurs when we see a pause in a strong uptrend: after a strong rise the stock is consolidating a bit and at some point the trend may be continued. Whether this actually happens can not be predicted of course, but it may be a good idea to keep and eye on NASDAQ:VRTX.

VRTX Daily chart on 2022-10-04

What is the technical picture of NASDAQ:VRTX telling us.

ChartMill assigns a Technical Rating to every stock. This score ranges from 0 to 10 and is updated daily. The score is determined by evaluating multiple technical indicators and properties.

Taking everything into account, VRTX scores 9 out of 10 in our technical rating. This is due to a consistent performance in both the short and longer term time frames. Also compared to the overall market, VRTX is showing a nice and steady performance.

  • Both the short term and long term trends are positive. This is a very positive sign.
  • When comparing the yearly performance of all stocks, we notice that VRTX is one of the better performing stocks in the market, outperforming 97% of all stocks. We also observe that the gains produced by VRTX over the past year are nicely spread over this period.
  • VRTX is one of the better performing stocks in the Biotechnology industry, it outperforms 94% of 635 stocks in the same industry.
  • VRTX is currently trading near its 52 week high. This is a good sign, definitely because the S&P500 Index is trading in the lower area of its yearly range.
  • In the last month VRTX has a been trading in the 276.57 - 299.59 range, which is quite wide. It is currently trading near the high of this range.
  • Prices have been rising strongly lately, it may be a good idea to wait for a consolidation or pullback before considering an entry.

Looking at the Setup

Next to the Technical Rating, the Setup Rating of a stock determines to which extend the stock is consolidating. This score also ranges from 0 to 10 and is updated daily. The setup score evaluates various short term technical indicators. For NASDAQ:VRTX this score is currently 8:

Besides having an excellent technical rating, VRTX also presents a decent setup pattern. We see reduced volatility while prices have been consolidating in the most recent period. There is very little resistance above the current price. There is a support zone below the current price at 287.58, a Stop Loss order could be placed below this zone. Very recently a Pocket Pivot signal was observed. This is another positive sign.

Trading breakout setups.

One way to play this would be to wait for the actual breakout to happen and buy when the stock breaks out above the current consolidation zone. A possible place for a stop loss would be below this zone.

Of course, there are many ways to trade or not trade NASDAQ:VRTX and this article should in no way be interpreted as trading advice. The article is purely based on an automated technical analysis and just points out the technical observations. Always make your own analysis and trade at your own responsibility.

Every day, new breakout setups can be found on ChartMill in our Breakout analyzer.

Back

VERTEX PHARMACEUTICALS INC

NASDAQ:VRTX (3/28/2024, 8:00:02 PM)

After market: 418.01 0 (0%)

418.01

+0.69 (+0.17%)

VRTX News

News Image8 hours ago - Investor's Business DailyCrispr Stock, A Cathie Wood Holding, Dives For The Fifth Straight Week — Here's Why

The company is working to launch its Vertex-partnered gene-editing drug for sickle cell disease and beta thalassemia.

News Image3 days ago - InvestorPlace3 Biotech Stocks to Buy for the Next Bull Run: March 2024

These biotech stocks to buy are well positioned for growth, and will generate solid returns for investors in the next bull run.

News Image3 days ago - BusinessInsider3 Biotech Stocks to Buy for the Next Bull Run: March 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips As we step into March 2024, the spotlight is turning towards the biotech sector...

News Image3 days ago - InvestorPlaceWall Street’s Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich

Some of the market’s favorite biotech stocks have created immense wealth, as evidenced with the recent weight-loss drug stock boom.

News Image4 days ago - AB NewswireFDA Approves Vertex Pharmaceuticals (NASDAQ:VRTX) VX-407 for Phase I Study in Groundbreaking Move Against Polycystic Kidney Disease”
News Image8 days ago - Vertex Pharmaceuticals IncorporatedVertex Announces FDA Clearance of Investigational New Drug Application for VX-407 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
News Image8 days ago - InvestorPlace3 Biopharma Stocks Predicted to Soar in Q2 2024

These biopharma stocks can produce massive returns for Q2 based on new product releases and international treatment approvals.

News Image9 days ago - InvestorPlaceFrom Six Figures to Seven: 3 Biotech Stocks Set to Make Millionaires

These biotech stocks to buy offer a gateway to long-term gains, on the back of groundbreaking healthcare innovations.

News Image10 days ago - Market News VideoVRTX September 20th Options Begin Trading
News Image11 days ago - The Motley Fool2 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now

It's always a good time to buy great stocks with excellent prospects.

News Image12 days ago - The Motley Fool3 Unstoppable Stocks You Can Buy Now Without Any Hesitation

There's no need for delays in buying these great stocks.

News Image12 days ago - The Motley FoolForget Tesla, Buy This Magnificent Healthcare Stock Instead

Vertex Pharmaceuticals already has a fantastic business, and it could get much bigger in the future.

VRTX Links
Follow us for more